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C. Diaz-Oreiro and J. M. Gutierrez. Chemical modification of histidine and 
lysine residues of myotoxic phospholipases A, isolated from Bothrops asper and 
Bothrops godmani snake venoms: effects on enzymatic and pharmacological 
properties. Toxicon 35, 241-252, 1997.-Lysine and histidine residues of two 
myotoxic phospholipases AZ, Bothrops asper myotoxin III and Bothrops 
godmani myotoxin I, were chemically modified in order to study the effects of 
these treatments on enzymatic and pharmacological properties. After lysine 
acetylation the overall basicity of these toxins was lost and their enzymatic 
activity was significantly reduced, although a residual effect remained, which 
corresponded to 25% of the activity of native toxins. This treatment abolished 
both myotoxic and anticoagulant effects, and partially reduced liposome-dis- 
rupting activity. Histidine alkylation with p-bromophenacyl bromide affected 
phospholipase A2, myotoxic and anticoagulant effects in a parallel way. After 
24 hr of incubation with the alkylating reagent, these three activities were 
totally inhibited, in contrast to the liposome-disrupting effect which was only 
partially affected by this treatment. It is suggested that: (1) catalytic activity 
plays a role in the pharmacological effects of these myotoxins; (2) lysine 
residues are relevant for the toxic effects induced by these phospholipases A?; 
and (3) despite the apparent relevance of enzymatic activity to the 
pharmacological properties of these toxins, the dissociation observed in lysine 
acetylation experiments uggests that these myotoxins have a molecular region. 
different from the catalytic site, which might be also involved in the toxic effects 
observed. 0 1997 Elsevier Science Ltd. All rights reserved 
INTRODUCTION 
Several basic phospholipases A* which induce myotoxicity have been purified from 
Bothrops snake venoms (Gutierrez and Lomonte, 1995). Although they share common 
biochemical and immunochemical properties, marked differences in catalytic activity have 
been observed. Some myotoxic phospholipases have high enzymatic activity, whereas 
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others either lack or have extremely low phospholipase AZ activity (Gutierrez and 
Lomonte, 1995). Several catalytically inactive variants have lysine instead of aspartate in 
position 49, a modification that impairs the enzyme’s ability to bind calcium, thereby 
affecting the catalytic mechanism (Francis et al., 1991; Cintra et al., 1993). 
It has been proposed that Lys-49 myotoxic phospholipases A, induce myotoxicity in viva 
and affect cells in culture by a mechanism independent of enzymatic phospholipid 
degradation (Gutierrez et al., 1989; Diaz et al., 1991; Gutierrez and Lomonte, 1995). It 
was hypothesized that enzymatically inactive myotoxic phospholipase-like variants have 
a molecular region that disrupts bilayers. It has been proposed that Bothvops asper 
myotoxin II, a Lys-49 variant (Francis et al., 1991), has a stretch of residues located at 
the C-terminal region, rich in hydrophobic and basic amino acids, responsible for cytolysis 
(Lomonte et al., 1994b). 
In the case of Asp-49 enzymatically active Bothrops myotoxic phospholipases AZ, the 
role of catalysis in their pharmacological effects has not been established. A dissociation 
between enzymatic and myotoxic activities has been observed with B. asper myotoxin I 
using monoclonal antibodies (Lomonte et al., 1992) and with B. asper myotoxin III in 
experiments with heparin (Lomonte et al., 1994a), EDTA (Bultron et al., 1993a) and 
chemical modification withp-bromophenacyl bromide (Bultron et al., 1993b). Thus, it was 
suggested that Asp-49 Bothrops myotoxins have a region, distinct from the catalytic site, 
which plays a role in myotoxicity (Bultron et al., 1993b; Gutierrez and Lomonte, 1995). 
This hypothesis needs to be tested using a variety of experimental protocols. 
Chemical modification is a useful approach to study this issue. In the present work we 
have chemically modified B. asper myotoxin III and Bothrops godmani myotoxin I by two 
different procedures: alkylation of histidine residues with p-bromophenacyl bromide and 
modification of lysine residues by acetylation. The effects of these treatments on the 
enzymatic and pharmacological activities of these myotoxic phospholipases A2 are 
described. 
MATERIALS AND METHODS 
Snake venom phospholipase5 
Bothrops asper myotoxin III (B. usper MT-III) and B. godmani myotoxin I (B. godmani MT-I) were purified 
by ion-exchange chromatography on CM-Sephadex C-25, as described by Lomonte and Gutiirrez (1989) and 
Diaz et al. (1992). respectively. Homogeneity was demonstrated by gel electrophoresis on two different systems: 
polyacrylamide gel electrophoresis (PAGE) at pH 4.5 (Reisfeld et al., 1962) and sodium dodecyl sulfate 
(SDSFPAGE (Laemmli, 1970). 
Lysine acetylation with acetic anhydride 
Modification of lysine residues was performed at a protein:reagent molar ratio of l:50. Protein (3 mg) was 
dissolved in 1.5 ml of 0.2 M Tris-HCI buffer, pH 8.0, and 10 ~1 of acetic anhydride (Aldrich, U.S.A.) was added. 
The pH was adjusted again to 8.0 with NaOH after the addition of acetic anhydride. After 1 hr of incubation 
at 25°C protein was separated from the free reagent by gel filtration on a Sephadex G-25 column equilibrated 
with 0.05 M ammonium acetate buffer, pH 6.8, then the protein was lyophilized. Control protein was subjected 
to gel filtration under the same conditions used for the protein incubated with acetic anhydride. PAGE was 
performed at pH 4.5 (Reisfeld ef (II., 1962) and pH 8.6 (Davis, 1964) to determine the charge characteristics of 
modified toxins. In addition, both native and modified toxins were analysed by high-performance liquid 
chromatography (HPLC; Waters 600E chromatograph with automatic injector Waters 712 WISP) on a 
reverse-phase C, column (Vydac) of 1 cm diameter and 25 cm length. Chromatographic separation was 
performed using a flow rate of 2 ml/min and a pressure of 1200 p.s.i. Elution was carried out with a linear 
gradient from 0 to 60% acetonitrile in 0.1% trifluoroacetic acid. 
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Modification with p-bromophenacyl bromide 
Modification of histidine residues was performed at protein:reagent molar ratio of 1:3. Protein (3 mg) was 
dissolved in I .O ml of 0.1 M Tris-HCI buffer, pH 8.0, containing 0.7 mM EDTA, and 125 pl ofp-bromophenacyl 
bromide (pBPB) solution (1.5 mg/ml in ethanol) was added. Incubations were carried out for 1, 3 and 24 hr at 
25’C. Protein was then separated from the free reagent by gel filtration on Sephadex G-25, as described for 
acetylation experiments. Control protein was incubated with 125 pi of ethanol and subjected to gel filtration 
under the same conditions. Proteins were then lyophilized. The protein concentration of dissolved samples was 
determined by recording the absorbance at 280 nm and by the method of Spector (1978). Amino acid analyses 
were performed in order to corroborate that histidine residues were modified. Protein samples (l-2 nmoles) were 
hydrolysed with 6 N HCI in sealed vials for 20 hr at 110’ C under vacuum. Amino acid composition was then 
determined using a Beckman 6300 amino acid analyser. 
Phospholipase A2 activity 
Enzymatic activity was tested using egg yolk phosphohpids as substrate. Egg yolk (1 ml) diluted I : 5 with 0. I 
M Tris, IO mM CaCl* buffer, pH 8.5, in the presence of 1% Triton X-100, was incubated with various amounts 
(I-30 pg) of either native or modified toxins for 20 min at 37°C. After incubation, free fatty acids were extracted 
and titrated according to the method of Dole (1956). The activity of modified toxins was expressed as a 
percentage, taking as 100% the enzymatic activity of the corresponding native toxins. 
Myotoxic activity 
SwisssWebster mice (18-20 g body weight) were injected i.m. in the right gastrocnemius with 80 pg of either 
native or modified myotoxins (dissolved in 80 pl of distilled water). Control mice received 80 pl of water. Animals 
were bled from the tail 3 hr after injection and blood was collected in heparinized capillary tubes and centrifuged 
to obtain the plasma. Creatine kinase (CK) activity in plasma was determined using the Sigma kit 520. Activity 
was expressed in units (U)/ml, 1 U resulting in the phosphorylation of I nmole of creatine per minute 
at 25°C. 
Eflkct on negatively charged liposomes 
Liposomes (I,-a-phosphatidylcholine, 63 pmoles; dicetyl phosphate, 18 pmoles; cholesterol. 9 pmoles; Sigma 
kit L-4262) were prepared as described by Diaz et a/. (1991). The effect of native and modified myotoxins on 
liposomes was tested in microtitre plates by incubating 20 pl of liposome suspension and 20 pl of solutions of 
varying concentration of myotoxins (8-500 pg/ml) for 30 min at 37 C. Then, 40 pl of peroxidase substrate 
(2.5 mM 5-aminosalycilic acid, 0.025% HzOZ, pH 6.0) was added and the colour reaction was stopped with 6 N 
HSO,. Absorbances were recorded at 492 nm. Absorbances of liposome samples incubated with only water were 
used as negative controls and subtracted from the absorbances of all experimental samples. Peroxidase release 
was expressed as a percentage, taking as 100% the absorbances of samples in which liposomes were incubated 
with 0.2% Triton X-100. 
Anticoagulant eff.kci 
Sheep platelet-poor plasma was prepared by centrifugation of titrated blood twice at 1000 g. Plasma (250 111) 
was incubated with various concentrations of toxins (0.001-20 pg/ml), dissolved in 100 pl of distilled water. 
Incubations were carried out for IO min at 37’C, 50 pl of 0.25 M CaCI, was added and clotting times were 
recorded. Observations were carried out for a maximum period of 45 min. 
Statistical ana(wis 
The Student’s f-test was used to determine the significance of the differences between the mean v,alues of two 
experimental groups. 
RESULTS 
Effects of’ lysine acetylation 
The overall basicity of both toxins was lost after treatment with acetic anhydride. since 
neither of them entered into polyacrylamide gels run at pH 4.5, in contrast to native toxins 
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(results not shown). In agreement with these observations, acetylated toxins behaved as 
acidic proteins on PAGE at pH 8.6. When analysed by reverse-phase HPLC, both native 
and modified toxins gave single peaks, although modified toxins eluted with higher 
retention times. 
Acetylation of lysine residues significantly reduced the enzymatic activity of both 
myotoxins (Table 1). However, a residual activity was detected, corresponding to 26% and 
24% of the activities of native B. asper MT-III and B. godmani MT-I, respectively. Lysine 
modification abolished myotoxicity induced by both myotoxins (Fig. 1). There was no 
significant difference (P > 0.1) in the plasma CK levels between mice injected with 
modified toxins and those injected with distilled water (Fig. 1). 
Liposome-disrupting activity of both myotoxins was significantly, but not totally, 
reduced after acetylation (Fig. 2). In the case of B. godmani MT-I this activity was 
significantly lowered at all toxin concentrations tested. However, in the case of B. asper 
MT-III liposome-disrupting activity was significantly reduced when tested at toxin 
concentrations of 0.125 mg/ml and 0.031 mg/ml, although no difference was observed 
between native and modified toxins at a concentration of 0.5 mg/ml (Fig. 2). At the 
concentrations tested, the anticoagulant effect of both myotoxins was eliminated as a 
consequence of lysine acetylation (Fig. 3). 
Effects of histidine alkylation 
Amino acid analysis of modified myotoxins indicated that treatment with pBPB resulted 
in the modification of one of the two histidine residues present in B. godmani MT-I and 
of the only histidine present in B. asper MT-III (results not shown). 
A time-dependent reduction in enzymatic activity was observed (Table 1). After 24 hr 
of incubation with pBPB, both toxins were devoid of catalytic activity. However, when 
toxins incubated with pBPB for 1 and 3 hr were tested, the phospholipase A, activity of 
B. asper MT-III was reduced to 35% and 22%, respectively. In contrast, the enzymatic 
activity of B. godmani MT-I remained at higher levels after incubation for 1 hr (89O/ 
residual activity) and 3 hr (71% residual activity; Table 1). 
Regarding myotoxic effect, B. asper MT-III was affected to a greater extent than B. 
godmani MT-I when treated with pBPB. After 1 hr of incubation with pBPB, the plasma 
CK activity of mice injected with modified B. asper MT-III corresponded to 18% of the 
CK levels of mice injected with native toxin (Fig. 4). Furthermore, when incubation with 
pBPB was extended to 24 hr, myotoxic activity of B. asper MT-III was abolished (Fig. 4). 
In the case of B. godmani MT-I, treatment with pBPB also affected myotoxicity, but to 
a lesser extent. After incubation times of 1 and 3 hr there was a reduced, but still 
significant, myotoxic effect (Fig. 4). However, when this myotoxin was treated with the 
alkylating reagent for 24 hr, myotoxicity was eliminated (Fig. 4). 
Table 1. Enzymatic activity of Bofhrops myotoxins after histidine alkylation and lysine acetylation 
Myotoxin Enzymatic activity after: 
p-Bromophenacylation Acetylation 
1 hr 3 hr 24 hr I hr 
B. asper myotoxin III 35 f 1.0% 22 f 1.0% 0% 26 &- 1.0% 
B. godmani myotoxin I 89 k 1.0% 11 f 2.2% 0% 24 k 1.0% 
Activity is expressed as a percentage, taking as 100% the enzymatic activity of native proteins. 
Results are presented as mean + S.D. (n = 3). 
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Fig. 1. Myotoxic effect of native and acetylated B. asper MT-III (A) and B. godmani MT-I (B). 
as judged by quantification of plasma CK levels. 
Acetic anhydride treatment of toxins was carried out for 1 hr at 25°C. Mice were injected with 
80 pg of each toxin and bled after 3 hr for determination of plasma CK levels. One CK unit results 
in the phosphorylation of 1 nmole of creatine per minute at 25’C. Results are presented as 
mean k S.D. (n = 6). 
Modification of histidine also affected the liposome-disrupting activity of myotoxins. As 
in the case of phospholipase A, and myotoxic activities, incubation with pBPB affected 
B. asper MT-III to a greater extent than B. godmani MT-I (Fig. 5). A significant 
liposome-disrupting effect was observed even in myotoxins treated for 24 hr, despite these 
modified toxins having lost their enzymatic and myotoxic activities. Regarding the 
anticoagulant effect, histidine modification drastically reduced the action of myotoxins on 
plasma recalcification times (Fig. 6). Again, as in the case of phospholipase, myotoxic and 
liposome-disrupting activities, B. asper MT-III was affected to a greater extent than B. 
godmani MT-I. However, the anticoagulant activity of both myotoxins was abolished when 
incubations with the alkylating reagent were carried out for 24 hr. 
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DISCUSSION 
Various myotoxic phospholipases A, have been purified from Bothrops snake venoms 
(Gutierrez and Lomonte, 1995). Some of them have high enzymatic activity, whereas 
others either lack or have extremely low catalytic effect, a finding that has been attributed 
to the presence of critical substitutions in residues forming the calcium-binding loop 
(Francis et al., 1991; Cintra et al., 1993). In this study we selected B. asper MT-III and 
B. godmani MT-I, two enzymatically active myotoxins, for chemical modification studies 
in order to investigate the role of lysine and histidine residues in their pharmacological 
and catalytic activities. 
As expected, lysine acetylation resulted in drastic changes in charge, both toxins 
becoming acidic as judged by their electrophoretic behaviour. This modification reduced 
A 0-0 native 
0.10 
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B H native T 
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Fig. 2. Effect of native and acetylated B. asper MT-III (A) and B. godmani MT-I (B) on negatively 
charged liposomes. 
Peroxidase-containing liposomes were incubated for 30 min at 37’C with either native or modified 
toxins, and peroxidase release was determined as detailed in Materials and Methods. Absorbance 
was recorded at 492 nm after addition of peroxidase substrate. Release is expressed as percentage, 
taking as 100% the peroxidase release from liposomes incubated with 0.2% Triton X-100. Results 
are presented as mean k S.D. (n = 6). 
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Fig. 3. Effect of native and acetylated B. asper MT-III (A) and B. godmani MT-I (B) on clotting 
time of sheep platelet-poor plasma. 
Toxins were incubated with plasma for IO min at 37°C. 0.25 M CaCll was added and clotting times 
were recorded. Observations were carried out for a maximum period of 45 min. Results are 
presented as mean k S.D. (n = 6). 
enzymatic activity to a value of about 25% of the activity of native enzymes. In contrast. 
both myotoxic and anticoagulant effects were totally abolished, whereas a residual 
liposomal-disrupting effect remained. Our findings agree with previous studies in which the 
lysines of several phospholipases A, from the venoms of Naja naja atra and Nqja nigricollis 
were modified by carbamylation (Condrea et al., 1981), methylation (Ho et al.. 1986). 
ethoxyformylation and guanidination (Condrea et al., 1983). These studies showed 
that such modifications had a greater effect on some pharmacological properties than 
on the enzymatic activity of the toxins, a conclusion also reached by Babu and Gowda 
(1994) after guanidination of lysine residues of a basic phospholipase A? from Vipera 
russelli. Thus, lysines seem to play a critical role in the toxicity of snake venom 
phospholipases A,. 
Acetylated myotoxins retained significant liposome-disrupting activity, indicating that 
these phospholipases can disrupt bilayers even after extensive lysine modification. The lack 
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of correlation between the ability of these toxins to induce liposome disruption and their 
myotoxicity agrees with previous observations of Diaz et al. (1991) and suggests that 
liposome and muscle membranes have different susceptibilities to these toxins. 
Furthermore, our results with acetylated myotoxins clearly show a dissociation between 
enzymatic and pharmacological (myotoxic and anticoagulant) activities, in agreement with 
previous studies with other phospholipases A, (Condrea et al., 1981, 1983; Ho et al., 1986; 
Babu and Gowda, 1994). These findings can be interpreted as evidence of the existence 
of molecular regions, distinct from the catalytic site, which may be responsible for at least 
some of the pharmacological properties of these toxins (Rosenberg, 1986; Kini and Evans, 
1989; Bultron et al., 1993b). Our results also suggest hat lysines play a role in the myotoxic 
and anticoagulant activities of these phospholipases A,. 
Alkylation of histidine residues with pBPB reduced the enzymatic activity of both 
myotoxins after incubations of 1 and 3 hr and, when treatment was extended to 24 hr, the 
catalytic effect was abolished. Bothrops asper MT-III was affected to a greater extent than 
B. godmani MT-I when incubations were performed for 1 and 3 hr. Interestingly, myotoxic 
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Fig. 4. Effect of B. asper MT-III (A) and B. godmani MT-I (B) treated with pBPB on plasma CK 
levels. 
pBPB treatment of toxins was carried out for periods of 1,3 and 24 hr at room temperature. Mice 
were injected i.m. with either native or modified toxins and CK levels were determined 3 hr after 
injection and expressed in U/ml. Results are presented as mean k SD. (n = 6). 
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Fig. 5. Effect of B. asper MT-III (A) and B. godmuni MT-l (B) treated with pBPB on negatively 
charged liposomes. 
Results are expressed as a percentage, taking as 100% the peroxidase release from liposomes 
incubated with 0.2% Triton X-100. Results are presented as mean k S.D. (n = 6). 
and anticoagulant activities of both myotoxins were affected to a similar extent as 
enzymatic activity. After 24 hr of incubation with the alkylating reagent both activities 
were eliminated. As in the case of lysine acetylation, different results were obtained with 
the liposome-disrupting effect, since a significant activity was retained even when 
enzymatic activity had been abolished. It has been observed that B. asper myotoxin I and 
B. atrox myotoxin, two catalytically active variants, disrupt liposomes in conditions where 
enzymatic activity is inhibited, i.e. when calcium is eliminated and EDTA added (Diaz 
et al., 1991). 
In contrast to our results, earlier studies provided evidence of residual myotoxic and 
cytotoxic effects in B. asper MT-III even after inhibition of enzymatic activity by 
incubation with EDTA (Bultron et al., 1993a) or by pBPB treatment (Bultron et ul., 
1993b). The discrepancy between our data and these earlier studies may be due to the use 
of pharmacological and enzymatic assay systems of different sensitivities. In the case of 
B. usper MT-III and B. godmuni MT-I, there was a parallelism between enzymatic activity 
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and myotoxic and anticoagulant effects after chemical modification with pBPB. Thus, 
pharmacological effects are likely to depend on the integrity of the catalytic active site and 
on enzymatic phospholipid hydrolysis. Alternatively, treatment with pBPB may induce 
conformational changes in other regions of the molecule responsible for the 
pharmacological effects induced by these toxins. Such conformational changes have been 
demonstrated by Renetseder et al. (1988) in the case of bovine pancreatic phospholipase 
A, after pBPB treatment. 
In conclusion, our results suggest hat the phospholipase A2 activity of B. asper MT-III 
and B. godmani MT-I is relevant to their myotoxic and anticoagulant effects. In addition, 
lysine residues are critical for the induction of these pharmacological activities. 
The dissociation observed between the enzymatic and pharmacological effects after 
lysine modification suggests that, in addition to the catalytic site, these myotoxins 
have a molecular region involved in their toxic effects. Both the catalytic site and this 
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Fig. 6. Effect of B. asper MT-III (A) and B. godmani MT-I (B) treated with pBPB on clotting times 
of sheep platelet-poor plasma. 
Toxins were incubated with plasma for 10 min at 37°C 0.25 M CaCl, was added and clotting times 
were recorded. Observations were carried out for a maximum period of 45 min. Results are 
presented as mean + S.D. (n = 6). 
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additional toxic region seem to be relevant in the pharmacological activities of these 
phospholipases A,. 
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